TCL Archive NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions. March 12, 2010
TCL Archive Auditor Raymond Weiss Finds “Incredible” Protocol Violations–26% Of Patients Were Ineligible For C225 Study June 21, 2002
TCL Archive NCI Director Klausner Resigns To Head Institute Begun By AOL Chairman Case. September 14, 2001
TCL Archive Master’s Program In Nurse Oncology Kept Alive; Final Decisions In February October 21, 1977